Currently, Anja Kammesheidt is Chief Scientific Officer of Exagen, Inc.

In her past career she held the position of Chief Scientific Officer for OmeCare Ventures, Inc. and Chief Scientific Officer for Ambry Genetics Corp.

She received an undergraduate degree and a doctorate from the University of California, Irvine.